Key terms
About OPK
OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the following segments: Diagnostics and Pharmaceuticals. The Diagnostics segment includes the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest OPK news
Apr 11
8:56am ET
Notable open interest changes for April 11th
Apr 03
6:26am ET
Opko Health Buy Rating Backed by Strategic Asset Sale and Promising Oral Drug Candidate
Apr 01
9:15am ET
Buy Rating Affirmed for Opko Health Amid Strategic Divestiture and Operational Improvement Prospects
Apr 01
7:10am ET
Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS), Opko Health (OPK) and Leafly Holdings, Inc. (LFLY)
Mar 28
8:42am ET
Opko Health Sells Diagnostics Business to LabCorp
Mar 28
8:03am ET
Labcorp to acquire select assets of BioReference Health for $237.5M
Mar 25
8:46am ET
Largest borrow rate increases among liquid names
Mar 22
8:46am ET
Largest borrow rate increases among liquid names
Mar 21
8:46am ET
Largest borrow rate increases among liquid names
Mar 20
8:46am ET
Largest borrow rate increases among liquid names
Mar 20
8:10am ET
Entera Bio announces PK data from oral GLP-2 peptide tablet treatment
Mar 05
9:06am ET
Opko Health’s ModeX presents results from Phase 1 study of SAR441236
Feb 29
8:45am ET
Largest borrow rate increases among liquid names
Feb 28
10:10am ET
Analysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN) and Opko Health (OPK)
Feb 28
9:52am ET
Opko Health price target lowered to $1.50 from $2 at Barrington
Feb 28
9:36am ET
NextPlat opens OPKO Health-branded storefront on Alibaba’s Tmall
Feb 28
6:32am ET
Analysts Offer Insights on Healthcare Companies: Esperion (ESPR), Beam Therapeutics (BEAM) and Opko Health (OPK)
Feb 27
4:45pm ET
Opko Health reports Q4 EPS (9c), consensus (10c)
Feb 27
3:34pm ET
Opko Health options imply 14.0% move in share price post-earnings
Feb 26
8:45am ET
Largest borrow rate increases among liquid names
Feb 10
4:27am ET
Opko Health Board Member Alexis Borisy to Depart
Jan 31
8:45am ET
Largest borrow rate increases among liquid names
Jan 25
4:20am ET
Opko Health Ends Share Lending Agreement with Jefferies
Jan 22
2:50pm ET
Fly Insider: Compass Diversified, Coinbase among week’s notable insider trades
No recent press releases are available for OPK
OPK Financials
Key terms
Ad Feedback
OPK Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
OPK Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
